ocular surface
Showing 26 - 50 of 6,412
Antiseptics, Microbiota, Conjunctiva Trial in Brescia (Povidone-Iodine 0.66%, Chlorhexidine 0.02%)
Completed
- Antiseptics
- +2 more
- Povidone-Iodine 0.66%
- Chlorhexidine 0.02%
-
Brescia, ItalyAzienda Socio Sanitaria Territoriale degli Spedali Civili di Bre
Aug 2, 2023
Graft Vs Host Disease Trial in Boston (DEXTENZA (dexamethasone ophthalmic insert) 0.4 mg, for intracanalicular use, Regular
Withdrawn
- Graft Vs Host Disease
- DEXTENZA (dexamethasone ophthalmic insert) 0.4 mg, for intracanalicular use
- Regular dissolvable intracanalicular plug
-
Boston, MassachusettsMass Eye and Ear
Dec 14, 2021
Keratoconus, Ocular Surface Disease, Pellucid Marginal Corneal Degeneration Trial in Needham (Ocular surface optical coherence
Completed
- Keratoconus
- +8 more
- Ocular surface optical coherence tomography
-
Needham, MassachusettsBostonSight
Mar 24, 2022
Myopia Trial (Atropine Sulfate)
Not yet recruiting
- Myopia
- Atropine Sulfate
- (no location specified)
Jul 20, 2022
Cataract, Dry Eye Syndromes, Cataract Senile Trial in Olathe (PROKERA)
Recruiting
- Cataract
- +3 more
- PROKERA
-
Olathe, KansasGrin Eye Care
Nov 25, 2021
Safety, Tolerability, Ocular Surface Trial in Guadalajara (Bepotastine Besilate)
Completed
- Safety
- +3 more
- Bepotastine Besilate
-
Guadalajara, Jalisco, MexicoUnidad Clínica de Bioequivalencia, S. de R.L. de C.V.
Dec 22, 2021
Hyperemia Eye Trial (Naphazoline / Hypromellose Ophthalmic)
Not yet recruiting
- Hyperemia Eye
- Naphazoline / Hypromellose Ophthalmic
- (no location specified)
Jul 22, 2022
Preservative-free Fixed-dose Combination of Tafluprost 0.0015% /
Completed
- Ocular Surface Disease
- Primary Open Angle Glaucoma
- Tafluprost, timolol maleate
-
Taoyuan city, TaiwanChang-Geng Medical Foundation Linkou Chang-Geng Memorial Hospita
Oct 27, 2022
Mesenchymal Stromal Cells, Cornea, Corneal Defect Trial (MSC Secretome Eye Drops)
Not yet recruiting
- Mesenchymal Stromal Cells
- +3 more
- MSC Secretome Eye Drops
- (no location specified)
Jan 11, 2022
Diacerein on Ocular Surface Disease in Degenerative Arthritis
Completed
- Ocular Surface Disease
- +2 more
-
Bangkok, ThailandFaculty of medicine, Chulalongkorn university
Aug 9, 2021
Antibiotic Resistance, Ocular Surface Microbiome, Gut Resistome Trial in San Francisco (Moxifloxacin (Topical))
Recruiting
- Antibiotic Resistance
- +2 more
- Moxifloxacin (Topical)
-
San Francisco, CaliforniaUniversity of California, San Francisco
Aug 2, 2022
Diabetic Retinopathy With Macular Edema of Both Eyes (Diagnosis), Central Retinal Vein Occlusion With Macular Edema, Exudative
Completed
- Diabetic Retinopathy With Macular Edema of Both Eyes (Diagnosis)
- +6 more
- Refresh Plus Preservative-free Lubricant Eye Drops
-
Iowa City, IowaUniversity of Iowa Hospitals & Clinics - Department of Ophthalmo
Apr 16, 2023
Intravitreal Injection, Ocular Rinse, Age-Related Macular Degeneration Trial in Oklahoma City (OSDI questionnaire, SPEEDII
Completed
- Intravitreal Injection
- +4 more
- OSDI questionnaire
- SPEEDII questionnaire
-
Oklahoma City, OklahomaDean McGee Eye Institute
Nov 7, 2022
Multimodal Screening of Dry Eye Disease
Recruiting
- Dry Eye Disease
- No Dye BreakUp Time
-
Le Kremlin-Bicêtre, Val De Marne, FranceOpthtalmology Departement, Bicêtre Hospital
Sep 5, 2022
Myopia Trial (Atropine Sulfate)
Not yet recruiting
- Myopia
- Atropine Sulfate
- (no location specified)
Jul 28, 2022
Pediatric Eye Care Investigated Team
Not yet recruiting
- Eye Diseases
- +3 more
- (no location specified)
Feb 8, 2022
Eye Diseases, Ocular Surface Disease, Dry Eye Trial in Kahramanmaras (OSDI, tear break up time, schirmer)
Completed
- Eye Diseases
- +2 more
- OSDI
- +2 more
-
Kahramanmaraş, In The USA Or Canada, Please Select..., TurkeyAbdullah Beyoğlu
Jul 2, 2021
Ocular Surface Disease, Ocular Inflammation Trial in Rome (CycloSPORINE Ophthalmic 0.1% Ophthalmic Emulsion, cationorm eye
Active, not recruiting
- Ocular Surface Disease
- Ocular Inflammation
- CycloSPORINE Ophthalmic 0.1% Ophthalmic Emulsion
- cationorm eye drops
-
Rome, ItalyUniversity Campus Bio Medico
Jan 5, 2022
Dry Eye Syndrome, Xerophthalmia Trial (Acupuncture, Oral microbiota, Schirmer's test)
Recruiting
- Dry Eye Syndrome
- Xerophthalmia
- Acupuncture
- +14 more
-
Taipei, TaiwanChing-Mao Chang
Dec 11, 2022
AST Combined With 0.05% Cyclosporin Eye Drop Improve Corneal
Completed
- Sjogren's Syndrome
- +2 more
- Autologous serum tears combined with 0.05% cyclosporin eye drop
-
Chengdu, Sichuan, ChinaHospital of Chengdu University of Traditional Chinese Medicine
Aug 25, 2023
Ocular Surface Disease Trial in Needham (cyclosporine ophthalmic emulsion 0.05%)
Withdrawn
- Ocular Surface Disease
- cyclosporine ophthalmic emulsion 0.05%
-
Needham, MassachusettsBostonSight
Jul 20, 2021
Immune Cell Signatures in Autoimmunity and Dry Eye Syndrome
Recruiting
- Autoimmunity
- Dry Eye Syndrome
- Cross-sectional study
-
Singapore, SingaporeCynthia Boo
Mar 22, 2022
Dry Eye Disease Trial in Lucca (Artificial tear MDI - 101)
Completed
- Dry Eye Disease
- Artificial tear MDI - 101
-
Lucca, ItalyOphthalmology unit
Dec 1, 2021
Dry Eye Syndromes Trial in Racine (Dextenza 0.4Mg Intracanalicular Insert, Over the counter Artificial tears)
Completed
- Dry Eye Syndromes
- Dextenza 0.4Mg Intracanalicular Insert
- Over the counter Artificial tears
-
Racine, WisconsinThe Eye Center of Racine
Apr 21, 2022